Alnylam Pharmaceuticals, Inc.

Vermillion & White Wealth Management Group, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/18/2026

Shares

16

Value ($000)

6

Weight

0.0%

2025 Q3 - 2025 Q4 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/18/2026	6	0.0%	16	12/31/2025
2025 Q3	11/26/2025	7	0.0%	16	9/30/2025